Industry: Healthcare | Publish Date: 09-Sep-2023 | No of Pages: 81 | No. of Tables: 65 | No. of Figures: 33 | Format: PDF | Report Code : N/A
Netherlands Cone-Beam Computed Tomography (CBCT) Systems Market was valued at USD 10.51 million in 2022, and is predicted to reach USD 19.86 million by 2030, with a CAGR of 7.35% from 2023 to 2030. Cone Beam Computed Tomography (CBCT), known by various names such as C-arm CT, cone beam volume CT, flat panel CT, or Digital Volume Tomography (DVT), is a specialized medical imaging method employed to generate three-dimensional images of different anatomical structures within the human body. This technique involves the use of a cone-shaped X-ray beam that revolves around the patient, capturing a sequence of two-dimensional X-ray images from multiple angles.
Subsequently, a computer reconstructs these images to produce intricate 3D depictions of the scanned region. CBCT technology finds widespread application in fields such as dentistry, oral and maxillofacial surgery, and orthodontics, offering a comprehensive perspective of the teeth, jaws, facial bones, and adjacent tissues. With its ability to capture images characterized by high spatial resolution and minimal distortion, CBCT enables healthcare practitioners to visualize anatomical structures with exceptional precision and accuracy.
The advantages of CBCT over traditional medical imaging techniques, such as conventional X-rays or CT scans, include lower radiation exposure, shorter scan times, and the ability to produce high-quality 3D images. This technology enables healthcare providers to plan and perform complex dental and surgical procedures more effectively, facilitating accurate diagnosis, treatment planning, and evaluation of treatment outcomes.
Thus, CBCT is an advanced imaging technique that employs cone-shaped X-ray beams and computer algorithms to generate detailed three-dimensional images of the human body, primarily used in dental and maxillofacial applications for improved diagnosis and treatment planning.
The market for Cone-Beam Computed Tomography (CBCT) in the Netherlands is experiencing significant growth owing to the increasing incidence of lip and oral cancer cases. As the country witnesses a rising number of individuals affected by these cancers, the demand for advanced imaging technologies like CBCT has surged.
CBCT's ability to provide detailed and precise three-dimensional scans of the oral and maxillofacial regions is invaluable for early detection, accurate diagnosis, and tailored treatment planning, thus driving its adoption in the Netherlands' healthcare landscape to better address the challenges posed by this growing public health concern. For instance, World Health Organization (WHO) data reveals that there were 1558 cases of lip and oral cavity cancer, which indicates there are greater opportunities for the CBCT market.
Furthermore, Phillips, a prominent global player, is actively contributing to the field of CBCT by providing advanced technology for the detection and treatment of lung cancer. This presence reinforces the efforts aimed at enhancing lung cancer detection and treatment through CBCT.
For instance, in September 2020, Philips launched a new 3D CT X-ray system specifically designed to expedite the diagnosis of lung cancer. The system combines the speed of computed tomography (CT) scans with advanced 3D imaging capabilities, allowing for accurate detection of lung nodules and other abnormalities associated with lung cancer. This innovative solution aims to enhance the efficiency of lung cancer diagnosis, enabling healthcare professionals to provide timely and effective treatment to patients.
Government support has been instrumental in propelling the growth of the Cone Beam Computed Tomography (CBCT) market, particularly in the Netherlands. Through the implementation of strategic initiatives and policies, governments have actively promoted and financially backed advanced healthcare technologies, including CBCT.
These actions not only enhance the accessibility of cutting-edge medical equipment but also incentivize healthcare providers to adopt CBCT systems. Consequently, the CBCT market has witnessed substantial expansion, ultimately benefiting both healthcare professionals and patients by facilitating early diagnosis, precise treatment planning, and overall improved healthcare outcomes.
As a result, the CBCT market has witnessed significant expansion, ultimately providing benefits to both healthcare practitioners and patients, including early disease detection, precise treatment planning, and overall enhanced healthcare outcomes.
The considerable expense associated with Cone Beam Computed Tomography (CBCT) machines can pose a notable impediment to the expansion of the CBCT market. The substantial initial investment needed to procure CBCT machines can dissuade healthcare facilities, especially smaller clinics or practices with constrained financial resources. This cost encompasses not just the acquisition of the machine but also includes expenses related to installation, maintenance, and training.
The financial burden associated with CBCT machines can limit their adoption, especially in regions with resource constraints or in healthcare settings where budget allocations are tight. This can restrict the availability and accessibility of CBCT technology, hindering its widespread implementation in various healthcare facilities.
The integration of Artificial Intelligence (AI) in CBCT software has the potential to revolutionize the field of imaging and significantly enhance the capabilities of CBCT technology. With AI algorithms, CBCT software can analyse and interpret images with greater precision and efficiency.
These algorithms can be trained to automatically detect and segment anatomical structures, lesions, and abnormalities, providing valuable insights to clinicians. By automating these tasks, AI integration can save time and improve diagnostic accuracy, ultimately leading to more effective treatment planning.
Additionally, AI-powered CBCT software can simulate and visualize treatment outcomes, enabling clinicians to better plan and communicate treatment options with patients. Whether it's virtual implant placement, orthodontic treatment simulations, or surgical planning, the integration of AI in CBCT software offers new possibilities for personalized and optimized patient care. It holds the promise of streamlining workflows, reducing manual labor, and enhancing the overall efficiency and precision of CBCT imaging in various medical and dental applications.
The Netherlands Cone-Beam Computed Tomography (CBCT) Systems industry includes several market players such as Dentsply Sirona, Koninklijke Philips N.V., Vatech Co., Ltd, Envista Holdings, Planmeca OY, J. Morita Mfg. Corp., Cefla S.C., Hefei Meyer Optoelectronic Technology INC, Xoran Technologies LLC, Acteon Group, Hitachi Ltd., Genoray Co Ltd, Asahi RoEntgen Ind. Co. Ltd., OSSTEM IMPLANT CO., LTD., Largev Instrument Corp. Ltd., Carestream Dental LLC, Curvebeam AI, and HDXWILL.
The Netherlands Cone-Beam Computed Tomography (CBCT) Systems market report provides a quantitative analysis of the current market and estimations through 2023-2030 that assists in identifying the prevailing market opportunities to capitalize on.
The study comprises a deep dive analysis of the market trend including the current and future trends for depicting the prevalent investment pockets in the market.
The information related to key drivers, restraints, and opportunities and their impact on the market is provided in the report.
The competitive analysis of the market players along with their market share in the Netherlands Cone-Beam Computed Tomography (CBCT) Systems market.
The SWOT analysis and Porter’s Five Forces model are elaborated in the study.
Value chain analysis in the market study provides a clear picture of the stakeholders’ roles.
Seated
Supine
Standing
Image Intensifier
Flat-Panel Detector
Small FOV Systems
Medium FOV Systems
Large FOV Systems
Dental
ENT Applications
Orthopedic Conditions
Neural & Spine
Lung Cancer
Veterinary
Dental Clinics
Hospitals
Others
REPORT SCOPE AND SEGMENTATION:
Parameters |
Details |
Market Size in 2022 |
USD 10.51 Million |
Revenue Forecast in 2030 |
USD 19.86 Million |
Growth Rate |
CAGR of 7.35% from 2023 to 2030 |
Analysis Period |
2022–2030 |
Base Year Considered |
2022 |
Forecast Period |
2023–2030 |
Market Size Estimation |
Million (USD) |
Growth Factors |
The rising prevalence of lip and oral cancer cases The government-driven initiatives. |
Companies Profiled |
18 |
Market Share |
Available for 18 companies |
Customization Scope |
Free customization (equivalent up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope. |
Pricing and Purchase Options |
Avail customized purchase options to meet your exact research needs. |
Dentsply Sirona
Koninklijke Philips N.V.,
Vatech Co., Ltd
Envista Holdings
Planmeca OY
J. Morita Mfg. Corp.
Cefla S.C.
Hefei Meyer Optoelectronic Technology INC
Xoran Technologies LLC
Acteon Group
Hitachi Ltd.
Genoray Co Ltd
Asahi RoEntgen Ind. Co. Ltd.
OSSTEM IMPLANT CO., LTD.
Largev Instrument Corp. Ltd
Carestream Dental LLC
Curvebeam AI
HDXWILL